Industry investment in dementia research

Investment from industry, such as pharmaceutical and biotech companies, is critical for advancing our understanding of dementia and developing new treatments and therapies for those living with dementia. Investment from industry can help accelerate the pace of research and improve the chances of finding life-changing treatments for dementia.

Translating Science into breakthroughs: the future of late-stage dementia clinical trials in the UK.

Business enterprise research and development, UK – Office for National Statistics (ons.gov.uk)

Strength and Opportunity 2017  The landscape of the medical technology, medical biotechnology, pharmaceutical and industrial biotechnology sectors in the UK; Office of Life Sciences and UK Trade and Investment.

Office of Health Economics for ARUK (in preparation).

Almost all phase 3 clinical trials in the UK are funded by industry

Office of Health Economics for ARUK (in preparation).